SMARCA4 and leukemia: Compared with Nalm-6/Sh-Ctrl cells, Nalm-6/Sh-BRG1 cells had a lower percentage and total number of human CD45+ leukemia cells in angular vein (Fig. 4B) and CD45 + CD19+ leukemia cells in bone marrow (BM) (Fig. 4D).